Skip to Main Content

Paper Details

A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Commun Biol
2
2022
Author NameAffiliation
Marlise R LuskinDana-Farber Cancer Institute
  • 1 - 1

Datasets

Release 1.2